<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 36 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page35.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=36">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 36 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 36</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=36"><img src="../thumb/36.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.2.1 / 1.2.2 / 1.2.3                                   2020-04 / 5
       proced. Furth. dos.of 1 mg may be giv.if necess.with total dos. great.  Side effects: Resp.depress., sedat., allerg.reacts, skin reacts.incl.  Adults: 7,5 mg shortly bef.retir.
       than 5 mg.usuall.not necess.  erythema multiforme & tox. epiderm. necrolys., photosens., nystagm.,   Elderly/imp.hepat.funct./chron.resp.insuffic./ren.insuffic:
       Elderly/debilit./chron.ill.pts: Init.1-1,5 mg.giv.5-10 mins.bef.pro-  atax., imp. judgem., paradoxic.excitem./restlessn./& confus.in elderly   Init.3,75 mg. If necess.may incr.to 7,5 mg.
       ced.Furth.dos.of 0,5-1 mg may be giv.as need.Tot.dos.great.than   or in pres.of pain, irritabil.& hyperexcitabil.in childr., folate defic.with   Contra-indications: Resp.fail., sev.sleep apnoea syndr., sev.hepat.
       3,5 mg usual.not. necess.     chron. admin., hypoprothombinaem.in infts.of mothers who receiv.  insuffic., myasthen.grav., childr. und. 18 yrs., safety in pregn.& lactat.
       Pre-op sedat: IM admin.shortly bef.proced. Adults &lt;60 yrs: 0,07-  dur.pregn., hepatit., cholestas.  not est., depress. /anx.with depress.as suicide may precipit.
       0,1 mg/kg bm. Usual dos. about 5 mg.  Special precautions: Drug depend., grad. withdr., tol.to hypnot.eff.  Side-effects: Dizzin., headache, resid.somnol., anterograde amnes.,
       Childr betw.1 & 15 yrs: Dos.range 0,08-0,20 mg/ kg bm admin.into   aft.prolong.admin., imp. ren./hepat.funct., elderly, sev.resp.insuffic.,   confus., hallucinat., aggressiven.& inappropriate behav., drowsin.,
       large musc.mass 30-60 mins, bef. anaesthes.induct.  alcoh. produc.poss.ser.resp.depress.& low.lethal dos.  inco-ordinat., bitt.taste, GI disturbs., prurit.& rash as hypersens.
       Elderly/debility./chron.ill pts: 0,025-0,05 mg/kg bm IM. Usual   Drug interactions: Effs.enhanc.by other sedat./ MAOI’s/other CNS   signs, rebound effs.
       dos: 2-3 mg.                  depress./some tranquillis.& poss. anticholinesterases /Na valproate/   Special precautions: Alcoh./drug abuse hist., poss. depend.,
       Anaesthes.induct: Admin.slow.IV approx.2,5 mg over 10 sec.ti-  sulphonylurea & TCA’s., phenothaiz.eff.init. enhanc. & subseq.dimin.,   ren./liv.insuffic., resp.insuffic., elderly, withdr.grad., 7-8 hrs.sleep
       trat.stepw.to desir.lev.Admin.in increm. of not more than 5 mg over   effs.dimin.by alkaline urine & poss.reserpine & folic acid, enhanc.ac-  recomm.to prev.anterograde amnes., not recomm.for prim. treatm.
       20-30 sec. allow.2 min.betw.success.increm. Pre-medicat. adults   tiv.of methotrex./ cyclophospham/sulphonylurea & tox. effs.of TCA’s,   of psychot.illn.
       &lt;60 yrs: Dos.range from 10-15 mg IV (0,15-0,2 mg/kg).Tot.dos.  metabol.of many meds.incr.by induct. of metabol.enzyme in liv.micro-  Drug interactions: Depress.effs of CNS depress. & alcoh.enhanc.,
       great.than 15 mg usual.not necess. Suffic.deep sleep lev.general.  somes reduc. activ. eg.carbamazepine/coumar.anticoags./ doxycycl./   cytochrome P450 enzyme inhibit. incr.effs., cytochrome P450 enzyme
       achiev.aft.2-3 mins.          folic acid/phenylbutazone/phenazone/ phenytoin/ corticoster./other   induc.decr. plasma conc.
       Non-pre-medicat.adults &lt;60 yrs: 0,3-0,35 mg/ kg bm. Tot.dos.  ster.hormon./ cyclospor./ metronidaz./quinidine/theophyl./TCA’s &   BETASLEEP, AI Pharm Ltd [P/S]
       great.than 20 mg usual.not necess. Elderly/debilit./chron.ill pts:   OC’s, activ.of oral griseofulvin.reduc.  Diphenhydramine HCl.
       Low.dos.requir.                                            Indications: Tempor.insomn.
       Anaesthes.maint: Contin.infus: Dos.usual.rang. from 0,03-0,1 mg/  (S2) CAPS. C/2.2/653.
       kg/hr when in combin.with narcot./ ketamine. Elderly/debilit./chron.  1.2.3  Others  754676-005: 50 mg, 12, R29,56
       ill/high risk surg.pts: Low.maint.dos.requir.              Dosage: 1-2 caps at bedt.approx.20 min.bef.retir.
       ICU sedat: IV: Indiv.Desir.sedat.lev.reach.by stepw. titrat.follow.  Contraindications: Epilep., pregn., lactat., childr. und.12 yrs.
       by contin.infus./intermit.bolus. IV load.dos.can range from 0,03-  ADCO-ZOLPIDEM HEMITARTRATE, AI Pharm Ltd [P/S]  Side effects: Lassit., dizz., GI disturb., headache, blurr.vis., tinnit.,
       0,3 mg/kg to be giv. in slow increm.each of 1-2,5 mg inj.over 20-30   Zolpidem hemitartrate.  dry mouth, musc.weakn.& inco-ordin.
       sec.allow.2 mins.betw.success.increm. Tot.dos. great. than 15 mg   Indications: Short-term insomn.treatm.when sev./ disabl./ex-  Drug interactions: Drowsin.aggrav.by CNS-depress. incl.alcoh.
       usual.not necess. Reduc./omit load.dos.in hypovol./ vasoconstrict./  trem.stressful.
       hypotherm.pts.                (S5) TABS. 36/2.2/0132       BIO ZOPICLONE 7,5, Biotech [P/S]
       Maint.dos: Rang.from 0,03-0,2 mg/kg/hr. Reduc. dos.in hypovol./  703809-001: 10 mg, 30, R117,40  Zopiclone
       vasoconstrict./hypotherm.pts, at times 25% of usual.dos. Sedat.  Dosage: Treatm.max.4 wks.incl.taper.off period.  Indications: Short-term insomn.treatm.in adults when disord.sev./
       lev.regular.assess.           10 mg immed.bef.bedt. Elderly, debilitat.& in hepat. insuffic:   disabl./extrem.stressf.
       Contraindications: Myasth.grav., sev.resp. insuffic., sleep apnoea   5 mg at bedt.  (S5) TABS. 42/2.2/0537
       syndr., sev.hepat.insuffic., safety in pregn.not est., lactat., IV admin.  Contraindications: Myasthen.grav., sleep apnoea, ac.& sev.pulm.  718473-001: 7,5 mg, 30, R51,44
       in childr. und.7 yrs.not recomm., not to be dilut.with Macrodex 6%   insuffic., sev.hepat. insuffic., childr.und.18 yrs., pregn., breast feed.,   Dosage: Init.low.recomm.dos. 1 tab.bef.retir. Do not exceed.dos.
       in Dextr./mix.with alkal.sol.  prim. treatm.of psychot.illn., alcoh/drug abuse hist.  Elderly/chron.resp.insuffic.: 3,75 mg init.then incr.to 7,5 mg if
       Side effects: Drowsin./over-sedat., CNS effs.incl. hallucinat., atax.,   Side effects: CNS effs., musc.weakn., atax., double vis., GI disturbs.,   necess. Treatm. durat.max. 4 wks.incl.taper.off per. Re-eval.if long.
       N & V, headache, hiccups, laryngosp., dyspn., anterograde amnes.  libido chang., skin reacts., anterograde amnes., unmask.of pre-exist.  treatm.per.reqd.
       which may be prolong., convuls.also in prem.infts.& neonates, hyper-  depress., psychiatr.& paradoxic.reacts., depend.& tol.  Contraindications: Resp.fail., sev.sleep apnoea syndr., sev.hepat.
       sens./anaphylact./skin reacts., loc.reacts. incl. thrombophlebit., decr.  Special precautions: Floppy inft.syndr.in neonates if admin.dur.  insuffic., myasth.grav., childr. und. 18 yrs., safety in pregn.& lactat.
                                     late pregn./labour, poss. physic.depend.& withdr.sympts.in neonates
       arter.BP, pulse & breath. chang., CV collapse follow.IV admin., resp.   not est., pre-exist. CNS depress./coma.
       depress./arrest &/card.arrest, paradox.reacts.  born to mothers chron.treatm.dur.late pregn., re-eval.for treatm.bey.  Side effects: CNS effs.incl.drowsin./anterogr. amnes./ dysarthr., diz-
                                     max.period, ensure 7-8 hrs.uninterrupt. sleep to reduc.risk of an-
       Special precautions: Admin.only in facilit.where resuscitat. readily   zin., headache, psych.effs., inappropr. behav., asthen., speech disord.,
       avail., pts.to remain in hosp.for 4 hrs. follow.parenter.admin., admin.  terogr.amnes., rebound insomn.on withdr.theref.withdr.grad., de-  trem., GI disturbs., bitt.taste, weight chang., skin reacts., paraesthes.,
                                     pend.risk great.in pts.with alcoh./drug abuse hist., resp. insuffic.,
       potent analges. 1  so sedat.eff.of midazolam can be titrat. accord.,   dyspn., palpitat., hypotens., bld. disords., urin.retent., incont., libido
               st
       indiv.dos.& contin.monit.of high risk pts., poss.floppy inft.syndr.if giv.to   depress., suicid.tendenc.  chang., jaund., hypersens. reacts., chills, sweat., rebound eff., withdr.
                                     Drug interactions: Enhanc.sedat.eff.with alcoh.& other CNS de-
       mothers dur. labour/ deliv., cross.placenta & into breast milk, elderly   press., cmpds.inhibit.hepat.enzymes partic. cytochrome P450 may   sympt.with abrupt.discont.
       pts.with organ.cerebr.chang./imp.card./ resp. funct., debilit./chronic.  enhanc.activ., cmpds. induc. hepat.enzymes partic.cytochrome P450   Special precautions: Women of child-bear. potent., pass.into
       ill pts., no alcoh. consumpt.for at least 12 hrs.aft.parent.admin., chron.  may reduc. hypnot.eff.  breast milk, abuse & depend. potent. esp.with prolong./high dos.,
       ren.fail., imp.hepat.funct., CHF, grad.withdr.             alcoh.& drug abuse hist., liv./kidn.funct.impairm., elderly, grad. dis-
       Drug interactions: Poss.enhanc.depress.eff.with anti-psychot./  ADCO-ZOPIMED, AI Pharm Ltd [P/S]  cont., allow for 7-8 hrs.sleep, not recomm.for prim.psychot.illn.treatm.,
       hypnot./anxiolyt./antidepress./ narcot. analges., anti-epilept.meds.,   Zopiclone  not to be used alone to treat depress./anx.with depress., concom.
       anaesthet./ sedat. antihistamin., poss.incr./prolong eff.with cmpds.   Indications: Short-term insomnia treatm.in adults.  CYP3A4 inhib./CYP3A4 induc.
       inhib.cert.hepat.enzym.esp.cytochrome P450 IIIA, eg cimetidine/rani-  (S5) TABS, 33/2.2/0450  Drug interactions: Depress.eff.of CNS depress. & alcoh.enhanc.,
       tidine/ erythromycin, diltiazem/verapamil/ketoconazole/itraconazole.  867365-005: 7,5 mg, 30, R54,09  effs. poss.incr. with cytochrome P450 enzym.inhib., decr.plasma
                                     Dosage: Admin.one tab. shortly bef.bedt. Do not exceed dos. El-  conc.with CYP3A4 induc.
                                     derly/liv./ren.funct.impairm./ chron. resp.insuff.pts: Init: ½ tab.   CIRCADIN, Takeda [P/S]
       1.2.2  Barbiturates           incr.to 1 tab.if reqd.       Melatonin
                                     Contraindications: Myasth.grav., resp.fail., sev. sleep apnoea
                                                                  Indications: Short term (3 wks.)treatm.of prim. insom.characteris.
                                     syndr., sev.hepat.insuff., childr. und. 18 yrs., safety in pregn.& lactat.  by poor sleep qual.in pts.≥ 55 yrs
       ADCO-PHENOBARBITONE VITALET, AI Pharm Ltd [P/S]  not est., not for depress. treatm.  (S4) PR TABS. 44/2.2/0001
       Phenobarb. 16 mg, Vit.B1 3 mg, B2 1 mg, B6 0,25 mg, nicotin.   Side effects: Bitt.aft.taste, CNS effs., psych.effs., GI disturbs., al-  721635-001: 2 mg, 30, R336,53
       10 mg/5ml.                    lerg./cutan.reacts., anterograde. amnes., psych.reacts., withdr.sympt.   Dosage: Take after food and swallow whole.
       Indications: Nerv.insomn., anticonvuls.in epilep., sedat.  & rebound insomn.if discont.abrupt.  Adults .≥ 55 yrs.: 2 mg once dly.1-2 hrs. bef. bedtime. Dos.may be
       (S5) ELIXIR. B1492.           Special precautions: Discont.grad., hist.alcoh./ drug abuse, de-  contin.for 3 wks. Effic.in pts.&lt;55 yrs. not demonstrate.
       754803-007: 100 ml, R101,13   pend.risk, reduc.effic.with rep.use, depress.sympt.mask.  Contraindications: Concom.fluvoxamine, safety in autoimm.dis./
       Dosage: Admin. 2-3xdly with water.  Drug interactions: Centr.depress.eff.enhanc.by CNS meds & alcoh.  pregn.& lactat.not est., hepat. impairm., childr.&adolesc.&lt; 18 yrs.
       Adults: 10 ml. Childr: 5-10 ml. Infts: 2,5-5 ml.  ALCHERA, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  due to insuffic. data,
       Contraindications: Ac.intermitt.porphyr., sev. resp. insuffic., hyper-  Zopiclone  Side effects: Herpes Zoster infects., leukopen., thrombocytopen.,
       kinet.childr., sev.ren./hepat. funct.impairm.  Indications: Short-term treatment of insomn.  hypertriglyceridaem., psych. disords. incl. irritabil., nervousn.,aggress,
       Side effects: Resp.depress., sedat., allerg. reacts.esp.skin reacts.  (S5) TABS, 33/2.2/0029  abnorm. dreams. agitat., crying, incr.libido., CNS disords. incl. mi-
       incl.Stev.-Johns.syndr./tox. epiderm.necrolys., CNS effs.with excess.  874728-002: 7,5 mg, 30, R53,10  graine, memory impairm.& attent.disturbs., reduc. vis.acuity, blurr.
       dos., hyperexcitabil.in childr., folate defic.dur.chron. admin.for epilep.,   Dosage: Adults: 1 tab.shortly bef.retir. This dos. should not to   vis., incr.lacrimat., position. vertigo, hot flush, GI disords incl.saliv.
       hypoprothrombinaem.in infts. whose mothers receiv.phenobarb.dur.  be exceed.  hypersecret., hyper-bilirubinaem., incr.hepat.enzym., abnorm. LFT/
       pregn., hepatit., cholestas., depend.  Elderly & debilitat: Init.½ tab. Depend.on effectiven. & tol.may   lab. test, hyperhidros., eczema, erythema, prurit. rash., prurit., dry
       Special precautions: Imp.hepat./ren.funct., suicid. pts., sev.pain   incr.to 1 tab.  skin, nail disord., night sweat., musc.cramp., neck pain, priapism,
       give concom.painkill.eg. aspir., elderly, withdr.grad.   Contraindications: Childr.und.18 yrs., resp.fail., sev. sleep ap-  asthen., fatig., incr.weight.
       Drug interactions: Barbit.act.enhanc.by other sedat./ MAOI’s/  noea syndr., sev.hepat.insuffic., safety in pregn.& lactat.not est.,   Warnings and special precautions: Lact. intol., probable exogen.
       anticholinesteras., Na valproate, sulphonylurea antidiab./TCA’s, en-  myasth.grav.  secret.in human milk, concom 5 or 8-methoxypsoralen/cimetidine/
       hanc.act.of methotrex./cyclophospham./sulphonurea/tox. effs. of   Side effects: Bitt.aft.taste, dizzin., headache, resid.somnol., GI dis-  oestrog., alcohol reduc.effectiv.of melatonin on sleep., ren.insuffic.
       TCA’s, ser.resp.depress with alcoh., poss. enhanc. eff.of anaesthet./  turbs., allerg.reacts., anterograde amnes., psych.reacts. more likely   eff.on melatonin pharmacokinets. not eval.
       antihistamin./narcot. analges., reduc.activ.of carbamazepine/cou-  in elderly, withdr.sympts., rebound insomn., inco-ordinat.on waking.  Drug interactions: Melatonin induc.CYP3A in vitro at supra-thera-
       marin anticoag./doxycycl./folic acid/phenylbutazone/ phenazone/   Special precautions: Elderly/debilitat., withdr. grad., ren./liv.im-  peut.conc.potent.reduc. plasma conc.of concom.meds., poss.interact.
       phenytoin/corticoster.& other steroid hormon. also griseofulvin if   pairm., rep.use, alcoh./drug abuse hist., poss.depend., depress.,   betw. melatonin & other act.subst.as conseq.of their eff. on CYP1A
       giv.per mouth concom.         cont.lact.                   enzymes, fluvoxamine incr. melatonin AUC & Cmax, 5 or 8-methoxyp-
       SEDABARB, Ranbaxy [P/S]       Drug interactions: Depress.eff of CNS depress. enhanc.  soralen/ cimetidine/ oestrog.incr.melatonin conc.by inhibit. metabol.,
                                                                  cigarette smok.decr.melatonin lev. due to CYP1A2 induct., CYP1A2
       Phenobarbitone.               AUSTELL-ZOPICLONE 7,5, (Austell) Camox [P/S]  inhibits.incl. quinolones incr.melatonin expos., CYP1A2 induc. ncl.
       Indications: Prophylact.treatm.of convuls.type epilep., gen.sedat.  Zopiclone  carbamazepine & rifampicin reduc.plasma conc., melatonin poss.
       (S5) TABS. E/2.3/107.         Indications: Short-term treatment of insomn. when disord.sev./  enhanc.sedat.props.of benzodiazep. & non-benzodiazep.hypnot.incl.
       814946-003: 30 mg, 1 000, R110,38  disabl./subj.indiv.to extreme stress  zalepon/ zolpidem/zopiclone.
       Dosage: Epilepsy: 1 tab.morn.& night.  (S5) TABS, A39/2.2/0022
       Hypnotic: 1 tab.1 hr.bef.bedt.  712508-001: 7,5 mg, 30, R55,56  IMOVANE, Sanofi-Aventis [P/S]
       Sedative: 1 tab.3xdly.        Dosage: Use low.recomm.dos.init. Do not exceed max.dos. Durat.  Zopiclone.
       Contraindications: Ac.intermitt.porphyr., sev. hepat. & ren.im-  of treatm.to be as short as poss. vary. from a few days to 2 wks.with   Indications: Short-term treatm.of insomn.in adults when sev./dis-
       pairm., hyperkinet.childr.    max.incl. taper. off process of 4 wks.  abl./subj.individ.to extr.stress.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page35.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page31.html">31</a>&nbsp;&nbsp;&nbsp;<a href="page32.html">32</a>&nbsp;&nbsp;&nbsp;<a href="page33.html">33</a>&nbsp;&nbsp;&nbsp;<a href="page34.html">34</a>&nbsp;&nbsp;&nbsp;<a href="page35.html">35</a>&nbsp;&nbsp;&nbsp;<a href="page36.html">36</a>&nbsp;&nbsp;&nbsp;<a href="page37.html">37</a>&nbsp;&nbsp;&nbsp;<a href="page38.html">38</a>&nbsp;&nbsp;&nbsp;<a href="page39.html">39</a>&nbsp;&nbsp;&nbsp;<a href="page40.html">40</a>&nbsp;&nbsp;&nbsp;<a href="page41.html">41</a>
             </td>
             <td width="35%"><a href="page37.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page37.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
